Evidence map›Paper›PMID 37783936›Full record

ArticleCellular and molecular life sciences : CMLS2023

Intracellular FGF1 protects cells from apoptosis through direct interaction with p53.

Agata Lampart, Daniel Krowarsch, Martyna Biadun, Vigdis Sorensen, Jakub Szymczyk, Katarzyna Sluzalska, Antoni Wiedlocha, Jacek Otlewski, Malgorzata Zakrzewska

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Agata LampartDepartment of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID http://orcid.org/0000-0001-7755-7761
Daniel KrowarschDepartment of Protein Biotechnology, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID http://orcid.org/0000-0003-2856-218X
Martyna BiadunDepartment of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-2648-6593
Vigdis SorensenAdvanced Light Microscopy Core Facility, Dept. Core Facilities, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway.ORCID http://orcid.org/0000-0002-1694-890X
Jakub SzymczykDepartment of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID http://orcid.org/0000-0003-2022-8064
Katarzyna SluzalskaDepartment of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-6307-0204
Antoni WiedlochaCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Oslo, Norway.ORCID http://orcid.org/0000-0003-3670-2330
Jacek OtlewskiDepartment of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID http://orcid.org/0000-0001-8630-2891
Malgorzata ZakrzewskaDepartment of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland. malgorzata.zakrzewska@uwr.edu.pl.ORCID http://orcid.org/0000-0001-8214-1533
University of Wrocław · PLOslo University Hospital · NOWrocław University of Science and Technology · PL

Funding

Narodowe Centrum Nauki 2015/18/E/NZ3/00501Narodowe Centrum Nauki 2018/31/N/NZ3/02257Narodowe Centrum Nauki 2020/02/Y/NZ3/00028
6 · The paper itself

Abstract

Fibroblast growth factor 1 (FGF1) acts by activating specific tyrosine kinase receptors on the cell surface. In addition to this classical mode of action, FGF1 also exhibits intracellular activity. Recently, we found that FGF1 translocated into the cell interior exhibits anti-apoptotic activity independent of receptor activation and downstream signaling. Here, we show that expression of FGF1 increases the survival of cells treated with various apoptosis inducers, but only when wild-type p53 is present. The p53-negative cells were not protected by either ectopically expressed or translocated FGF1. We also confirmed the requirement of p53 for the anti-apoptotic intracellular activity of FGF1 by silencing p53, resulting in loss of the protective effect of FGF1. In contrast, in p53-negative cells, intracellular FGF1 regained its anti-apoptotic properties after transfection with wild-type p53. We also found that FGF1 directly interacts with p53 in cells and that the binding region is located in the DBD domain of p53. We therefore postulate that intracellular FGF1 protects cells from apoptosis by directly interacting with p53.

Indexed as

Fibroblast Growth Factor 1Tumor Suppressor Protein p53ApoptosisReceptor Protein-Tyrosine KinasesSignal TransductionFibroblast Growth Factor 1Receptor Protein-Tyrosine KinasesTumor Suppressor Protein p53Anti-apoptotic activityApoptosisFibroblast growth factor 1 (FGF1)Intracellular functionp53Protein–protein interaction

Identifiers

PMID37783936
PMCPMC10545594
OpenAlexW4387245456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.